Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Haematologica|April 13, 2004
Intrauterine growth restriction and genetic predisposition to thrombophiliaFranca Franchi, Irene Cetin, Tullia Todros, et al.
Blood Advances|April 22, 2022
Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2Omid Seidizadeh, Luciano Baronciani, Maria Teresa Pagliari, et al.
Thrombosis Research|November 22, 2020
Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factorsEugenia Biguzzi, Filippo Castelli, Willem M Lijfering, et al.
Journal of Thrombosis and Haemostasis : JTH|September 30, 2020
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand diseaseEugenia Biguzzi, Simona Maria Siboni, Saskia le Cessie, et al.
Journal of Thrombosis and Haemostasis : JTH|February 8, 2023
Genetic determinants of enhanced von Willebrand factor clearance from plasmaOmid Seidizadeh, Luciano Baronciani, Maria Teresa Pagliari, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|April 15, 2004
Expression of endothelial protein C receptor and thrombomodulin in human coronary atherosclerotic plaquesPiera Angelica Merlini, Marco L Rossi, Elena M Faioni, et al.
Critical Care Medicine|May 1, 2004
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel diseaseElena M Faioni, Stefano Ferrero, Gessica Fontana, et al.
Human Mutation|February 16, 2005
Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT studyEugenia Biguzzi, Cristina Razzari, David A Lane, et al.
Blood|October 26, 2023
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposureLinda Schönborn, Olga Esteban, Jan Wesche, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2023
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPSMaria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, et al.
Pageof 3